Peptide record

TPDB01804

peptide from Okara protein - soybean lipoxygenase-1 ACE inhibitors Antihypertensive Antioxidant standard
7 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB01804
peptide from Okara protein - soybean lipoxygenase-1
ACE inhibitors Antihypertensive Antioxidant
Cardiometabolic peptides Functional / health-promoting peptides
Peptipedia AHTPDB AHTpin AnOxPePred - 1.0 AODB AoXpDb Multi-AOP
standard
No
A 7-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, and Antioxidant) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
TIIPLPV
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C37H65N7O9
ARNDCEQGHKMFSWY
IP
751.96
6.02
0
0
4
-0
-2.32
1.871
208.57
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
1
L
0
K
0
M
0
F
2
P
0
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 1 K: 0 M: 0 F: 0 P: 2 S: 0 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
7 reviewed residue count
C37H65N7O9 sequence-only estimate (linear, free termini)
751.96 sequence-only estimate (linear, free termini)
6.02 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-2.32 sequence-only estimate (linear, free termini)
1.871 sequence-only estimate (linear, free termini)
751.9509 Activity
751.4828 Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

EC50
ACE inhibitors
0.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: XM02-001)
ACE inhibitor
ah

Source & Reference

NA
Jiménez-Escrig A., Alaiz M., Vioque J., Rupérez P.
Health-promoting activities of ultra-filtered okara protein hydrolysates released by in vitro gastrointestinal digestion: identification of active peptide from soybean lipoxygenase. Eur. Food Res. Technol., 230 (2010), 1-9.
2010
Journal

Other

7
Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: XM02-001 Peptide obtained by sequential hydrolysis of Okara protein by use of pepsin A and pancreatin. Okara is a little market value by-product obtained during the manufacturing of soymilk and tofu.
Evidence 2 Activity

Activity

EC50
Antihypertensive
0.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: XM02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Jiménez-Escrig A., Alaiz M., Vioque J., Rupérez P.
Health-promoting activities of ultra-filtered okara protein hydrolysates released by in vitro gastrointestinal digestion: identification of active peptide from soybean lipoxygenase. Eur. Food Res. Technol., 230 (2010), 1-9.
2010
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
7
Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: XM02-001 Peptide obtained by sequential hydrolysis of Okara protein by use of pepsin A and pancreatin. Okara is a little market value by-product obtained during the manufacturing of soymilk and tofu.
Evidence 3 Activity

Activity

Antioxidative activity
Antioxidant

Source & Reference

AODB AoXpDb
DFBP
Additional Detail Fields 1 fields
7